Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / GENOMICS IMMUN
-
Total 13F shares
-
1,775,633
-
Share change
-
-159,292
-
Total reported value
-
$46,871,606
-
Price per share
-
$26.39
-
Number of holders
-
64
-
Value change
-
-$4,662,042
-
Number of buys
-
21
-
Number of sells
-
26
Institutional Holders of ISHARES TR - GENOMICS IMMUN (IDNA) as of Q3 2022
As of 30 Sep 2022,
ISHARES TR - GENOMICS IMMUN (IDNA) was held by
64 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,775,633 shares.
The largest 10 holders included
Wharton Business Group, LLC, MORGAN STANLEY, Wealthcare Advisory Partners LLC, UBS Group AG, BANK OF AMERICA CORP /DE/, COMMONWEALTH EQUITY SERVICES, LLC, LPL Financial LLC, ROYAL BANK OF CANADA, Kestra Advisory Services, LLC, and AMERIPRISE FINANCIAL INC.
This page lists
64
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.